GlassScriptPhysician profile
Peter Francis Via
NPI 1235441833
$545.42
in general payments reported to CMS, 2019-2025
10 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $49.42 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.36 |
| Education | $134.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $284.39 | 2024-2025 | Erleada |
| Tolmar, INC. | $45.43 | 2025 | Jatenzo, Eligard |
| Ferring Pharmaceuticals INC. | $44.79 | 2024-2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Urogen Pharma, INC. | $31.54 | 2025 | |
| Sumitomo Pharma America, INC. | $25.87 | 2025 | Orgovyx |
| Caris Mpi, INC. | $23.97 | 2025 | Mi Cancer Seek |
| Pfizer INC. | $19.79 | 2025 | |
| Organon LLC | $18.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Via listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.